Tests meal replacement products for weight and blood sugar in low-income adults
Studies meal replacements for weight loss and blood sugar in adults with obesity or diabetes.
Key facts
- Who runs it
- Massachusetts General Hospital
- Where
- Boston, United StatesSee the site
- Trial code
- Registry title
- Medically Intensive Nutrition Therapy Program for Obesity and Diabetes in a Low-income Population
- Status
- Recruiting
- People taking part
- 20 people, planned
- Started
- 28 Mar 2023
- Planned end
- 10 Nov 2026
- Type of study
- Observational
- Treatments tested
- Bariatrix Meal Replacement Products
- Record updated
- 24 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for low-income adults with overweight or obesity and raised blood sugar or diabetes, to test whether meal replacements help with weight loss and blood sugar.
- Age
- 18 to 65 years
- Sex
- All sexes can join.
- Disease stage
- BMI of 27 kg/m^2 or higher. HgA1C of 5.7 percent or higher, or fasting glucose of 100mg/dL (5.6 mmol/L) or higher, within the previous 6 months. HbA1c must be below 10 percent.
- Earlier treatment
- People cannot be using diabetes drugs other than metformin, or approved weight-loss drugs, now or in the next 3 months.
- Biomarker or test result
- HgA1C of 5.7 percent or higher, or fasting glucose of 100mg/dL (5.6 mmol/L) or higher, within the previous 6 months.
Main reasons for not taking part
- Family income above 400 percent of the 2022 federal poverty level
- HbA1c of 10 percent or higher
- Plans for bariatric surgery within the next 6 months
- Weight loss of more than 5 kg (11 lb) in the previous 3 months
- Pregnant, breastfeeding, or considering pregnancy within the next 6 months
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Age 18-65
- Body mass index (BMI) greater than or equal to 27 kg/m\^2
- HgA1C greater than or equal to 5.7 percent or fasting glucose greater than or equal to 100mg/dL within the previous 6 months
- Low-income as defined by having a family income at or below 400 percent of the federal poverty level guidelines for 2022
Who cannot take part
- Current use of antihyperglycemic agents (other than metformin) or approved anti- obesity medications or plans to start such regimens over the 3 months post-study enrollment
- Plans to pursue bariatric surgery over the 6 months post-study enrollment
- Weight loss of greater than 5 kg within the previous 3 months
- Current active eating disorder, with the exception of binge eating disorder
- Severe active psychiatric disease or significant cognitive impairment deemed by investigator likely to impede adherence to piloted intervention
- HbA1c greater than or equal to 10 percent
- Active illicit substance abuse
- Pregnant, breastfeeding, or considering pregnancy within the next 6 months
- Current participation in another clinical research trial deemed by investigator to conflict with current study
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Where in United States
- Massachusetts General HospitalBoston, United StatesContact: Chika V Anekwe, MDTaking people
About the trial
What the trial wants to find out
This study is being done to better understand whether meal replacements can be an effective tool for weight loss and treatment of elevated blood sugars in people with obesity/overweight and diabetes/pre-diabetes who have a low income.
The group in the trial
- Adults with overweight/obesity and pre-diabetes/diabetes and low income
Adults with overweight or obesity and pre-diabetes or type 2 diabetes who earn a low income.
Treatment: Bariatrix Meal Replacement Products
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Feasibility Study of an Intensive Nutrition Therapy Program for Improvement of Obesity and Diabetes in a Low-income Population
- Plain-language title
- Tests meal replacement products for weight and blood sugar in low-income adultsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT05799222, who can take part
- Record updated
- 24 December 2025